Oral Anticoagulants Market Report Is A Complete Overview Of The Market, Covering Various Aspects Product Definition, Segmentation Based On Various Parameters, And The Prevailing Vendor Landscape. This Study Also Analyzes The Market Status, Market Share, Growth Rate, Future Trends, Market Drivers, Opportunities And Challenges, Risks And Entry Barriers, Sales Channels, Distributors.
Market Highlights
The Global Oral Anticoagulants Market Is Expected To Grow At CAGR Of 12.50% To Reach USD 22,561.24 Million By 2023
Anticoagulant is a drug, when added to blood, prevents it from clotting. Anticoagulants achieve their effect by suppressing the synthesis or function of various clotting factors that are normally present in the blood. Such drugs are often used to prevent the formation of blood clots (thrombi) in the veins or arteries or the enlargement of a clot that is circulating in the bloodstream.
Increasing cardiovascular disorders, rising geriatric population, and increasing surgical procedures support the growth of the global oral anticoagulants market in recent years. However, the high cost is likely to restrain market growth over the forecast period.
Fill Out Details To Receive FREE Sample Here:
https://www.marketresearchfuture.com/sample_request/7718
Market Research Future (MRFR) recognizes the following companies as the key players in the global oral anticoagulants market that includes AstraZeneca, Plc (UK), Pfizer (US), Boehringer Ingelheim GmbH (Germany), Daiichi Sankyo Company Ltd (Japan), Abbott Laboratories (US), Eli Lilly and Company (US), GlaxoSmithKline plc (UK) Portola Pharmaceuticals Inc. (US), Medicure (Canada), Johnson & Johnson Services Inc. (US), and others.
Key Findings of the Study:
- Global oral anticoagulants market is projected to reach USD 22,561.24 million by 2023 with 12.50% CAGR during the review period of 2018 to 2023
- Americas accounted for the largest share due to in the region
- The atrial fibrillation (AF)/stroke prevention segment, is accounted for the largest share, holding a market value of USD 49 in 2017.
- Some of the players operating in the oral anticoagulants market are AstraZeneca, Plc, Pfizer, Boehringer Ingelheim GmbH, Daiichi Sankyo Company Ltd, Abbott Laboratories among others.
Segment Analysis
The global oral anticoagulants market has been segmented into product, disease indication, distribution channel, and region. Based on product, the oral anticoagulants market has been segmented into novel oral anticoagulant and warfarin. On the basis of disease indication, the global oral anticoagulants market has been segmented into atrial fibrillation (AF)/ stroke prevention and deep vein thrombosis/ pulmonary embolism, and others. On the basis of distribution channel, the global oral anticoagulants market has been segmented into hospital pharmacies, retail pharmacies, and E-commerce.
Browse Complete Report Details @ https://www.marketresearchfuture.com/reports/oral-anticoagulants-market-7718
Regional Analysis
Geographically, the Americas is expected to dominate the global oral anticoagulants market. This is owing to increasing cardiovascular disorders and increasing surgical procedures. Europe showed a considerable amount of growth in the market due to the rising geriatric population. Asia-Pacific is estimated to be the fastest growing region in the market. This is owing to increasing cardiovascular disorders and rising geriatric population. On the other hand, the Middle East & Africa has the least share of the market.
This research report provides the insights, on various levels of analyses such as industry analysis, market share analysis leading market players and their profiles. This report also helps in studying the target segments by providing views on emerging & high-growth segments and market conclusion. Together the market data comprise and discuss with the basic assessments on the competitive scenarios & strategies, of the Global Oral Anticoagulants Market, including the high-growth regions and their political, economic and technological environments. Furthermore, the project report also provides the views over the historical market values as well as, pricing and cost analysis of the same.
Related Reports
- Peptide and Anticoagulant Drugs Market Research Report – Forecast to 2023
- Blood Coagulation Testing Market Research Report – Global Forecast till 2023
- Blood Screening Market Research Report – Global Forecast till 2023
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Your information will never be shared with any third party.